bannertutte

A new zoner in our center of excellence

MolMed S.p.A., a biotechnological company focused on research, development and clinical validation of innovative therapies for cancer treatment...

has signed an agreement concerning the future location of a property within the “Open Zone” and science park and belonging to Zambon pharmaceutical group, preparatory to the implementation of the enlargement of the company’s productive capacity.

NEWS

  • Jul 16

    A new zoner in our center of excellence

    MolMed S.p.A., a biotechnological company focused on research, development and clinical validation of innovative therapies for cancer treatment...